Edo Kaluski is a Cardiology physician affiliated with SUNY Upstate Medical University. OpenAlex indexes 283 publications with 6,826 citations (h-index 38). By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JanssenProgram year202520 paymentsResearch$72,718openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202511 payments
- PFIZER INC.Program year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.2%Beta blocker18.4%Metoprolol Succinate66%Carvedilol11%Atenolol8%Metoprolol Tartrate7%Sotalol6%Propranolol Hcl Er2%Part D<11 patientsStatin17.7%Atorvastatin Calcium67%Pravastatin Sodium17%Rosuvastatin Calcium16%Part D≥102 patients+ 14 more classes in this area
Blood & clotting
12.2%Factor Xa inhibitor8.4%Eliquis77%Xarelto23%Part D≥48 patientsP2Y12 inhibitor3.8%Clopidogrel84%Brilinta16%Part D<11 patientsMetabolism & gastrointestinal
9.6%Potassium supplement5%Potassium Chloride81%Klor-Con M1019%Part D<11 patientsSGLT2 inhibitor4.3%Jardiance90%Farxiga10%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sodium‐Glucose Cotransporter‐2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta‐Analysis of Randomized Trials and Systematic Review
Journal of the American Heart Association
2023 - Trends in premature mortality from acute myocardial infarction in the United States, 1999 to 2019
eCommons - AKU (Aga Khan University)
2022 - Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
Annals of Internal Medicine
2019 - Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Journal of the American Heart Association
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Ross, MD
SUNY Upstate Medical University
Andras Perl, MD
SUNY Upstate Medical University
Ruth Weinstock, MD
SUNY Upstate Medical University
Jade Homsi, MD
SUNY Upstate Medical University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”